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Heart formation in vertebrates and fruit flies requires signaling by bone morphogenetic proteins (BMPs) to cardiogenic
mesodermal precursor cells. The vertebrate homeobox gene Nkx2–5 and its Drosophila ortholog, tinman, are the earliest
known markers for the cardiac lineage. Transcriptional activation of tinman expression in the cardiac lineage is dependent
on a mesoderm-specific enhancer that binds Smad proteins, which activate transcription in response to BMP signaling, and
Tinman, which maintains its own expression through an autoregulatory loop. Here, we show that an evolutionarily
conserved, cardiac-specific enhancer of the mouse Nkx2–5 gene contains multiple Smad binding sites, as well as a binding
site for Nkx2–5. A single Smad site is required for enhancer activity at early and late stages of heart development in vivo,
whereas the Nkx2–5 site is not required for enhancer activity. These findings demonstrate that Nkx2–5, like tinman, is a
direct target for transcriptional activation by Smad proteins; however, the independence of this Nkx2–5 enhancer of Nkx2–5
binding suggests a fundamental difference in the transcriptional circuitry for activation of Nkx2–5 and tinman expression
during cardiogenesis in vertebrates and fruit flies. © 2002 Elsevier Science (USA)INTRODUCTION
Recent studies indicate that heart formation is controlled
by an evolutionarily ancient developmental program, many
aspects of which are conserved between vertebrates and
insects (reviewed in Bodmer, 1995; Fishman and Olson,
1997). In vertebrates, heart formation begins soon after
gastrulation, when cells within a bilaterally symmetric
region of the anterior lateral plate mesoderm, known as the
cardiac crescent, adopt a cardiac fate in response to signal-
ing from the adjacent endoderm (reviewed in Nascone and
Mercola, 1996). Studies performed in amphibian and chick
embryos have demonstrated that bone morphogenetic pro-
teins (BMPs) mediate cardiogenic induction by the
endoderm (Schultheiss et al., 1995, 1997). Similarly, forma-
tion of the heart-like organ in Drosophila, the dorsal vessel,
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All rights reserved.is dependent on the BMP-related factor, Dpp, which is
secreted by the ectoderm and induces underlying dorsal
mesodermal cells to become cardiogenic (Frasch, 1995; Xu
et al., 1998).
BMP belongs to the transforming growth factor  (TGF)
superfamily. Signaling by this superfamily of growth factors
is mediated by effectors, called Smad proteins. Three
classes of Smads have been defined: the receptor-regulated
Smads (R-Smads), the co-Smad (Smad4), and the inhibitory
Smads (I-Smads). BMP signaling results in phosphorylation
of cytoplasmic R-Smads 1, 5, or 8, which then interact with
Smad4, followed by translocation of the heteromeric Smad
complex to the nucleus, where it associates with other
transcription factors to activate specific BMP-responsive
genes (reviewed in Attisano and Wrana, 2000; Massague and
Chen, 2000). Smad proteins bind DNA relatively weakly
alone, but are recruited to specific target genes via their
interactions with distinct transcriptional cofactors. The
ability of BMP signaling to induce specific mesodermal
cells to commit to a cardiac fate requires the interpretation
of BMP signals in a cell type-specific manner. Understand-
ing the mechanism that mediates this selective response to
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BMP signaling is likely to provide insight into the molecu-
lar basis for cardiac specification, which is poorly under-
stood.
The earliest molecular marker for cardiac development in
Drosophila is the NK-type homeobox gene tinman (Bodmer
et al., 1990; Azpiazu and Frasch, 1993; Bodmer, 1993).
tinman, which is essential for heart formation, is initially
expressed throughout the entire mesoderm, before becom-
ing restricted to dorsal mesodermal cells that give rise to
the dorsal vessel (Bodmer et al., 1990; Azpiazu and Frasch,
1993; Bodmer, 1993). Activation of tinman transcription by
Dpp is mediated by binding of the Smad4 ortholog Medea to
a dorsal mesoderm-specific enhancer (tin-D) that also binds
other activators and repressors, including the Tinman pro-
tein itself (Xu et al., 1998). Binding of Tinman to this
control region fulfills a positive autoregulatory loop that
reinforces and maintains tinman expression. However, the
Tinman binding sites are not required for Dpp responsive-
ness of the tin-D enhancer (Xu et al., 1998).
By comparison, the vertebrate ortholog of tinman,
Nkx2–5 (Komuro and Izumo, 1993; Lints et al., 1993), is
expressed throughout the cardiac crescent concomitant
with cardiogenic induction (Harvey, 1996). Attempts to
rescue heart formation in tinman mutant embryos using
vertebrate NK-type homeobox genes have shown that the
functions of Nkx2–5 and tinman are at least partially
conserved (Park et al., 1998; Ranganayakulu et al., 1998).
Nkx2–5 transcription has been shown to be controlled by a
complex series of positive and negative regulatory ele-
ments. However, despite embryological data directly impli-
cating BMP signaling in vertebrate cardiogenesis (Schul-
theiss et al., 1997; Shi et al., 2000), it is unclear whether
BMP signaling and its effectors act directly on the Nkx2–5
gene or whether there are intermediate steps in Nkx2–5
activation by BMP.
Two cardiac enhancers, referred to as activating region
(AR) 1 and AR2, in the 5-flanking region of the mouse
Nkx2–5 gene (reviewed in Schwartz and Olson, 1999),
direct overlapping, but subtly different patterns of expres-
sion that recapitulate endogenous Nkx2–5 expression in
the cardiac crescent and early heart tube (Searcy et al.,
1998; Lien et al., 1999; Reecy et al., 1999; Tanaka et al.,
1999). These enhancers also show activity in the pharynx,
thyroid, stomach, and spleen, where Nkx2–5 is expressed.
Both of these enhancers contain essential binding sites for
the GATA family of zinc-finger transcription factors
(Searcy et al., 1998; Lien et al., 1999). However, binding of
GATA factors alone cannot account for the specificity of
Nkx2–5 expression because GATA factors are expressed in
many noncardiac tissues (Morrisey et al., 1996, 1997).FIG. 1. Cross-species comparison of Nkx2–5 5-flanking se-
quences (A). Schematic diagram of 5-flanking regions of chicken,
mouse, and human Nkx2–5 genes. The AR1, AR2, and AR3
enhancers (Schwartz and Olson, 1999) are in red, and regions of
homology are indicated in gray. An additional homologous region
between mouse and human sequences surrounding 1285 and
2130, respectively, has not been shown to possess transcriptional
activity. The transcriptional start site is marked as 1. Exon 1a is
an alternative 5 exon. B, BamHI; E, EcoRI. (B). Comparison of the
mouse Nkx2–5 AR2 enhancer with chicken and human sequences.
Binding sites for known cardiac transcription factors are marked.
The two essential GATA sites and the essential Smad site are
marked with asterisks (**).
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FIG. 2. Mutagenesis of HNF-3, Nkx2–5, and E-box consensus sequences in the Nkx2–5 AR2 enhancer. F0 transgenic embryos harboring
lacZ transgenes linked to (A) the wild-type Nkx2–5 upstream region (3050/186) or the same region with mutations in the HNF-3 (B),
E-box (C), or Nkx2–5 (D) sites were isolated at E11.5 and stained for lacZ expression. Sites are shown in Fig. 1B. The HNF-3 site at -3006
(CTCTGTTTGCTT) was mutated to CCCCGGGTGCTT. The E-box at 2841 (CATCTG) was mutated to CCCGGG. The Nkx2–5 site
(AAAGTG) at 2943 was mutated to CCCGGG. h, heart; s, stomach.
FIG. 3. Expression of wild-type and Smad-mutant Nkx2–5 enhancer at E11.5. F0 transgenic embryos harboring lacZ transgenes linked to
the wild-type Nkx2–5 upstream region (3050/186) (A, C, E, G) or the same region with a mutation in the Smad site at 2774 (B, D, F,
H) were isolated at E11.5 and stained for lacZ expression. The posterior regions of the embryos in (A) and (B) were removed to allow
visualization of the heart and stomach. (C–H) H&E sections of the embryos in (A) and (B) at different levels. Expression in the heart,
pharynx, and thyroid is lost in the mutant, but expression in the stomach is retained. h, heart; lv, left ventricle; oft, outflow tract;
p, pharynx; rv, right ventricle; s, stomach; t, thyroid.
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Whether these enhancers can respond to early BMP signal-
ing within the cardiac crescent or later has not been
investigated.
To further understand the mechanisms that control
Nkx2–5 transcription in the developing heart, we analyzed
the 5-flanking regions of the mouse, chicken, and human
Nkx2–5 genes for sequences conserved between the three
species, and we compared the Nkx2–5 cardiac enhancers
with the tinman tin-D enhancer. Here, we show that the
AR2 enhancer of Nkx2–5 is highly conserved in mouse,
chicken, and human, and that this enhancer, like the tin-D
enhancer, contains conserved Smad and Nkx2–5 binding
sites. One of the Smad sites, which is adjacent to the two
essential GATA sites (Searcy et al., 1998), is essential for
activity of the enhancer in the cardiac crescent and in later
stages of heart development in vivo, but is not required for
expression in the developing spleen or stomach. In contrast,
the Nkx2–5 site is not required for enhancer activity at any
developmental stage we analyzed. Our data suggest that
Nkx2–5 is a direct downstream target of Smad4, and also
reveal differences between the transcriptional circuits that
control Nkx2–5 and tinman expression in the developing
cardiac lineages of vertebrates and fruit flies.
MATERIALS AND METHODS
Cloning, Mapping, and Sequencing cNkx2–5
Genomic DNA
Four chicken Nkx2–5 genomic clones were isolated from a
chicken genomic library (Stratagene) by using a fragment of a
chicken Nkx2–5 cDNA as a probe. Positive clones were purified
through secondary and tertiary screening and phage DNA was
isolated. The genomic DNA of chicken Nkx2–5 was subcloned into
pBluescript, and 10 kb of 5-flanking DNA was sequenced and
compared with mouse sequences by using the FASTA programs
provided in the GCG software package.
Plasmid Constructions
All mouse Nkx2–5 nucleotide coordinates are related to the
transcriptional start site. Transgenes were created by cloning DNA
fragments into the lacZ expression vector pAUG-Gal. The en-
hancer fragment of the mouse Nkx2–5 5-flanking region encom-
passing nucleotides 3050 to 186 relative to the transcriptional
start site was PCR-amplified by using primer Y1 (5-CCCAA-
GCTTGGGCTGCTCATCCATCAGCCAG) and Y2 (5-CCCAAG-
CTTGGGCCAGGTGGGTAGCAGAGAG) and subcloned into
pAUG-Gal. The enhancer-containing fragment 3050/186/
Smad was generated by mutating the conserved Smad site at
position 2774 to a SmaI site in the context of the 3050/186
enhancer fragment. Similarly, the conserved HNF-3 binding site at
3006 (CTCTGTTTGCTT), the E-box at 2841 (CATCTG), and
the Nkx2–5 binding site at 2943 (AAAGTG) were mutated to a
SmaI site in the context of the same fragment.
Gel Mobility Shift Assay
Protein–DNA binding was assessed by gel mobility shift assays
using glutathione S-transferase (GST) fusion proteins. The MH1
domain of Smad4 fused to GST was expressed from plasmid
pGEX-Smad4 (MH1) in bacterial strain BL21-CodonPlus (Strat-
agene). Binding to the conserved Smad site located between nucle-
otides 2800 and 2750 was tested by using double-stranded DNA
oligonucleotides with the sequence 5-TAGGAAGATAAAGC-
TACGGATAACGCTGCCTGTCTCCAATGGACGTCTCCC; the
conserved Smad site is underlined. Expression and purification of
the fusion proteins were done according to the procedures of Guan
and Dixon (1991), and gel shift assays were performed as described
(Lien et al., 1999). The mutant competitor oligonucleotide se-
quence is identical, except that the Smad site was mutated into a
SmaI site. The Smad site was also tested for its binding to
full-length GST-Smad1, Smad2, Smad3, and Smad4 (Cascade Bio-
science).
Generation of Transgenic Mice, -Galactosidase
Staining, and Histology
DNA for pronuclear injection was gel-purified and eluted by
using a QIAquick kit (Qiagen). Transgenic mice were generated and
embryos were analyzed as described previously (Lien et al., 1999).
RESULTS
Cross-Species Conservation of the Nkx2–5
Enhancer
The mouse Nkx2–5 gene is controlled by a complex array
of positive and negative regulatory regions located up-
stream, downstream, and within the gene (reviewed in
Schwartz and Olson, 1999). The majority of Nkx2–5 tran-
scripts are encoded by two exons. However, a subset of
transcripts is spliced to either of two alternative 5 exons
(Reecy et al., 1999; Tanaka et al., 1999). Exon 1a, the most
5 alternative exon, is located approximately 4 kb upstream
of the exon 1 (Fig. 1A). There are independent cardiac
enhancers at 9437/8922 and 3059/2554 upstream of
Nkx2–5, referred to as AR1 and AR2, respectively (Fig. 1A)
(Searcy et al., 1998; Lien et al., 1999; Reecy et al., 1999;
Tanaka et al., 1999; Schwartz and Olson, 1999). Through-
out the text, we refer to DNA sequence positions relative to
the major transcription initiation site at exon 1.
In an effort to identify possible evolutionarily conserved
regulatory elements, we isolated chicken Nkx2–5 genomic
clones and compared the sequences of the chick and mouse
5-flanking regions. Within 10 kb of 5-flanking sequence,
we identified a 470-bp segment with approximately 75%
identity between the two species (Fig. 1B). This region of
the mouse sequence, corresponding to the AR2 enhancer,
directs lacZ reporter gene expression in the cardiac crescent
and throughout the linear heart tube before becoming
restricted to the outflow tract (Searcy et al., 1998). This
enhancer is also active in the pharynx, thyroid, stomach,
and spleen (Searcy et al., 1998; Lien et al., 1999). We did not
identify any other significantly conserved regions between
chick and mouse sequences within the 10-kb upstream
regions (Fig. 1A). Within the conserved enhancer region are
two GATA sites that are essential for enhancer activity in
the heart and spleen (Searcy et al., 1998).
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We also compared the mouse genomic sequence with
the working draft sequence of human chromosome 5
(NT_023169.6; AC008412 (Sparrow et al., 2000)) and
thereby identified several stretches of homology between
mouse and human sequences (Fig. 1A). Strikingly, the
mouse and human sequences of the AR2 cardiac enhancer
show a high degree of homology (Figs. 1A and 1B). In addi-
tion, we identified a 303-bp fragment within the AR1 en-
hancer and a short region between AR2 and the promoter
that are also highly conserved between mouse and human
(Fig. 1A; and data not shown). The sequence conservation of
the two enhancers suggests that the mechanisms of Nkx2–5
gene regulation are highly conserved between chicken,
mouse, and human.
Mutagenesis of Transcription Factor Consensus
Sites in the AR2 Enhancer
There are six conserved binding sites for GATA transcrip-
tion factors in the AR2 enhancer (Fig. 1B), two of which
have been shown to be essential for enhancer activity in
heart and spleen (Searcy et al., 1998). In an effort to identify
other transcriptional activators of this enhancer, we fo-
cused on binding site consensus sequences that were con-
served in the mouse, human, and chicken enhancers, in-
cluding sites for forkhead transcription factor HNF-3, basic
helix–loop–helix (bHLH) proteins, Nkx2–5, and Smads. As
an initial test of the importance of these sites, we system-
atically mutated the binding site consensus sequences
within the context of fragment 3050/186, which con-
tains the transcription start site and the AR2 enhancer, and
analyzed the expression of a linked lacZ reporter gene in F0
transgenic mouse embryos at E11.5. At this stage, the
3050/186 fragment directs reporter gene expression in
the outflow tract of the heart, as well as in the pharynx,
thyroid, and the distal portion of the stomach (which also
eventually contributes to the spleen) (Searcy et al., 1998;
Lien et al., 1999) (Figs. 2A, 3A, 3C, 3E, and 3G). A minimum
of three independent F0 transgenic embryos was analyzed
for each mutant construct.
A potential binding site for HNF-3, which is expressed in
endoderm-derived tissues (Kaestner et al., 1994), is present
at 3006. An enhancer with a mutated HNF-3 site was
fully active in the outflow tract heart, pharynx, thyroid, and
stomach (Fig. 2B; and data not shown). This result indicated
that this site was not required for AR2 enhancer activity in
these tissues at E11.5.
Several bHLH transcription factors, which bind the E box
consensus sequence (CANNTG), play important roles in
cardiac development (Srivastava et al., 1995; Nakagawa et
al., 1999). Therefore, the presence of a conserved E-box at
2841 of the AR2 enhancer suggested that the enhancer
might be regulated by cardiac bHLH factors. However, the E
box mutation did not abolish enhancer activity in the
cardiac outflow tract or in other tissues at E11.5 (Fig. 2C;
and data not shown).
It has been shown that tinman expression in the dorsal
vessel of Drosophila requires binding of the Tinman protein
itself to the tin-D enhancer, which has been proposed to
fulfill a positive autoregulatory loop (Xu et al., 1998). There
are two binding sites for Tinman in the tin-D enhancer (Xu
et al., 1998). The presence of a highly conserved Nkx2–5
site at 2943 in the AR2 enhancer (Fig. 1B) suggested that,
like Tinman, Nkx2–5 might regulate its own expression by
binding to this sequence. However, an enhancer with this
site mutated still directed lacZ expression in the outflow
tract of the heart, pharynx, thyroid, and stomach (Fig. 2D).
This result indicates that the Nkx2–5 site in the AR2
enhancer is not required for maintaining enhancer activity
in vivo, and that unlike the tin-D enhancer of tinman, the
AR2 enhancer is not directly regulated by Nkx2–5, at least
at this stage of embryogenesis.
It should be pointed out that although the HNF-3, bHLH,
and Nkx2–5 binding sites were not absolutely essential for
enhancer activity at E11.5, we cannot rule out the possibil-
ity that they might be required for qualitative or quantita-
tive effects on expression at other developmental stages.
Indeed, the remarkable level of cross-species homology of
these sites and surrounding sequences suggests their in-
volvement in some aspects of Nkx2–5 regulation.
A Highly Conserved Smad Site in the Nkx2–5 AR2
Enhancer Is Required for Enhancer Activity during
Both Early and Late Cardiac Development
In addition to the transcription factor binding sites de-
scribed above, there are multiple conserved GTCT (AGAC
on the opposite strand) sequences at 3038, 3027, 2774,
and 2758 in the AR2 enhancer that are highly conserved
between chicken, mouse, and human sequences (Fig. 1B).
These GTCT/AGAC sequences are potential binding sites
(Zawel et al., 1998; Johnson et al., 1999) of Smad proteins,
downstream effectors of TGF/BMP signaling (Figs. 1B and
1C). Among these potential Smad sites, the one at 2774 is
adjacent to the two essential GATA sites (Searcy et al.,
1998). In addition, GTCT/AGAC boxes are often present as
tandem repeats, and the Smad site (2774) adjacent to the
essential GATA sites consists of two tandem repeats of the
sequence G(C/T)CTGTCT (Fig. 1B).
BMP has been shown to mediate induction of cardiogen-
esis and Nkx2–5 expression in chick embryos (Schultheiss
et al., 1997; Andree et al., 1998). However, it is unclear
whether the regulation of Nkx2-5 by BMP signaling and its
effectors is direct or indirect and whether Nkx2–5 is regu-
lated by BMP signaling in the mouse. The presence of
conserved Smad binding sites in the chick and mouse
enhancers suggests that mouse Nkx2–5 might also be
regulated by BMP signaling. To test whether the potential
Smad site at 2774 was required for enhancer activity in
the heart, we mutated this site in the context of fragment
3050/186 and assayed for enhancer activity in vivo.
In contrast to the wild-type enhancer, which shows
prominent expression in the outflow tract of the heart,
pharynx, thyroid, and the distal part of the stomach at E11.5
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(Searcy et al., 1998; Lien et al., 1999) (Figs. 3A, 3C, 3E, and
3G), no cardiac expression was detected in 10 F0 embryos
harboring the enhancer with the mutated Smad site (Figs.
3B and 3D). That these embryos retained expression in
stomach demonstrated that the transgene was functional
and that this Smad binding site was not required for
expression in these tissues (Fig. 3H). Interestingly, expres-
sion in the pharynx and thyroid was also abolished by the
Smad site mutation (Fig. 3F; and data not shown).
To determine whether the Smad-mutant enhancer might
be active at other stages of cardiac development, we gener-
ated three stable lines of transgenic mice harboring the
mutant transgene. Like the F0 embryos, there was no
cardiac expression of lacZ in these stable transgenic lines at
E11.5, although expression in the stomach and spleen was
retained (data not shown). Similarly, at E7.75, when the
wild-type enhancer (3050/186 fragment) drives lacZ
reporter gene expression in the cardiac crescent (Searcy et
al., 1998; Fig. 4A), there was no expression detected in the
cardiac crescent in any embryos from the three stable lines
harboring the transgene with the mutant Smad site (Fig.
4B). Thorough analysis of lacZ expression from these stable
lines throughout embryogenesis and after birth also failed
to reveal lacZ staining, in contrast to the wild-type en-
hancer, which is active at these stages (data not shown).
These results demonstrate that the Smad site at 2774 is
required for cardiac activity of the Nkx2–5 AR2 enhancer
from the earliest stage of cardiac specification in vivo.
Interestingly, while BMP signaling has been implicated in
activation of Nkx2–5 in the cardiac crescent, the possibility
that it might be required to maintain Nkx2–5 expression at
later stages has not been addressed. The finding that the
Smad site is essential at both early and late developmental
stages analyzed suggests a potential role for BMP signaling
or other TGF signaling beyond the initial step in cardio-
genic specification.
Binding of Smad4 to the Highly Conserved Smad
Site in the Nkx2–5 AR2 Cardiac Enhancer
GTCT boxes can be bound by either Smad3 or Smad4
(Dennler et al., 1998; Zawel et al., 1998) or the Smad1/
Smad4 complex (Johnson et al., 1999). In light of the
essential role of Medea, an ortholog of Smad4, as a direct
regulator of the tin-D enhancer in Drosophila (Xu et al.,
1998), we tested whether mouse Nkx2–5 was a direct target
FIG. 4. Expression of wild-type and Smad-mutant Nkx2–5 en-
hancer at E7.75. Embryos from transgenic mouse lines harboring
lacZ transgenes linked to the wild-type Nkx2–5 upstream region
(3050/186) (A) or the same region with a mutation in the Smad
site at 2774 (B) were isolated at E7.75 and stained for lacZ
expression. All lacZ expression in the cardiac crescent (cc) is lost in
the mutant.
FIG. 5. Binding of Smad4 to the Smad site (2774) in the Nkx2–5
AR2 enhancer. (A) Binding of Smad4 (MH1) to the Smad site. A
32P-labeled oligonucleotide probe encompassing the Smad site from
the Nkx2–5 AR2 enhancer was used in gel mobility shift assays
with the MH1 domain of Smad4 expressed as a GST fusion protein,
as described in Materials and Methods. The GST-Smad4 (MH1)-
DNA complex was competed specifically with excess unlabeled
probe, but was not effectively competed by a mutant probe.
Fold-excess of competitor DNA compared with labeled probe is
shown. The first lane on the left has no competitor. No DNA–
protein complex was observed with GST alone. (B) Binding of
full-length Smad4 to the Smad site. Full-length Smad1, Smad2,
Smad3, and Smad4 were expressed as GST fusion proteins and gel
mobility shift assays were performed as described above. Only
GST-Smad4 bound to the Smad site.
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of Smad4. There are potential Smad3/4 binding sites at
3038,3027,2774, and2758 in the AR2 enhancer that
are highly conserved between chicken, mouse, and human
sequences (Figs. 1B and 1C). Among these potential Smad
sites, the one at 2774 is adjacent to the two essential
GATA sites (Searcy et al., 1998).
We tested whether Smad4 could bind to the conserved
sequence at 2774, using GST-Smad fusion proteins and an
oligonucleotide encompassing this putative Smad site in a
gel mobility shift assay. As shown in Fig. 5A, a GST fusion
protein containing the amino-terminal MH1 domain of
Smad4, which can bind DNA in a ligand-independent
manner (Zawel et al., 1998), bound avidly to this DNA
sequence. Binding was competed by unlabeled wild-type
oligonucleotide, but was competed poorly by the same
amount of oligonucleotide in which the Smad binding site
was mutated. GST alone did not bind to the oligonucleo-
tide. GST-Smad4 (MH1) bound to the oligonucleotide as
two differently migrating complexes (Fig. 5A). Both com-
plexes could be supershifted by Smad4 antibodies, suggest-
ing that GST-Smad4 (MH1) may bind this sequence as both
monomers and dimers (Fig. 5A).
To test whether full-length Smad4 and/or other Smad
proteins can also bind to this element, we performed a gel
mobility shift assay using GST fusion proteins of full-
length Smad1, 2, 3, and 4. As shown in Fig. 5B, only
GST-Smad4 was able to bind to the potential site, while
Smad1, 2, and 3 had no binding activity. Therefore, we
conclude that the GCCTGTCT sequence at 2774 in the
AR2 enhancer is a cognate Smad4 binding site and that
Nkx2–5 is regulated directly by TGF/BMP signaling
through Smad4.
DISCUSSION
The transcriptional regulation of mouse Nkx2–5 is ex-
tremely complex, involving multiple positive and negative
regulatory elements distributed in the 5- and 3-flanking
regions of the gene (reviewed in Schwartz and Olson, 1999).
Within the 23-kb genomic region examined in four studies
(Searcy et al., 1998; Lien et al., 1999; Reecy et al., 1999;
Tanaka et al., 1999), multiple enhancers that direct expres-
sion in heart, spleen, stomach, thyroid, and pharynx have
been identified. In order to further delineate the cardiac
enhancers, we compared the 5-flanking regions of mouse,
chick, and human Nkx2–5. Our results show that the AR2
enhancer, which is located 3 kb upstream of the transcrip-
tion start site (Fig. 1A), is highly conserved between the
three species. The AR1 enhancer, which is located 9 kb
upstream (Fig. 1A), is also conserved between mouse and
human (data not shown). However, we have not identified
any homologous sequences to the AR1 enhancer within the
10-kb upstream region of chick Nkx2–5. Whether an AR1
FIG. 6. Comparison of the tinman tin-D and Nkx2–5 AR2 enhancers. The tinman and Nkx2–5 enhancers are shown schematically.
Tinman and Nkx2–5 binding sites are in yellow. Medea/Smad4 binding sites are shown in pink, and Mad binding sites are in black. The
two essential GATA sites in the AR2 enhancer are marked with asterisks (**). The M2A and M4 sequences in the tin-D enhancer are Medea
binding sites described in Xu et al. (1998) and Raftery and Sutherland (1999). The core GTCT sequences are indicated in pink beneath the
tin-D schematic. Sequence homologies between the AR2 and tin-D enhancers in the region surrounding the essential Smad site in the AR2
enhancer are shown at the bottom. This region also shows homology to the core of the AR1 mouse enhancer (Lien et al., 1999).
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homologous region is located outside this region of chicken
genomic DNA remains to be determined. There is also a
cardiac regulatory region located 887 bp upstream of alter-
native 5 exon 1a (Reecy et al., 1999), referred to as AR3
(Schwartz and Olson, 1999). We have not identified any
sequence in chick or human genomic DNA with homology
to the AR3 enhancer (Reecy et al., 1999).
An important principle that has emerged from studies of
other cell type-specific enhancers is that precise temporo-
spatial control of transcription requires complex interac-
tions among large numbers of transcription factors that
bind overlapping and adjacent DNA sequences (reviewed in
Davidson, 2000). While the studies reported here and else-
where (Searcy et al., 1998; Liberatore et al., 2002) demon-
strate the essential roles of the Smad and GATA sites for
regulation of the AR2 enhancer, based on the extensive
cross-species homology of this enhancer, it is likely that
sequences throughout this region play important roles in
fine-tuning the Nkx2–5 expression pattern. Additional
studies will be required to determine the identities of such
factors and to understand the molecular basis for their
interactions.
Comparison of the Regulation of Drosophila
tinman and Mouse Nkx2–5 Expression
The organization of the tinman tin-D and vertebrate
Nkx2.5 enhancers is schematized in Fig. 6. There are four
putative Smad4 binding sites, GTCT/AGAC, that are con-
served in the AR2 enhancer (Fig. 1B). It has been shown that
the tinman tin-D enhancer contains eight Mad binding
sites, three of which can also be bound by Medea (Xu et al.,
1998). The consensus sequence of the Mad and Medea
binding sites is the GC-rich sequence, CGCCGC (Xu et al.,
1998; Nguyen and Xu, 1998). However, for the sites that can
also be bound by Medea, such as the M2 and M4 sites in the
tin-D enhancer, there is an AGAC/GTCT sequence adja-
cent to the GC-rich sequence (Fig. 6; Xu et al., 1998). This
AGAC/GTCT sequence is identical to the vertebrate
Smad4 binding site. Thus, it is likely that Medea actually
binds to the AGAC/GTCT sequences instead of the GC-
rich sequence.
Multiple Mad/Medea binding sites in the tin-D enhancer
are required for dorsal mesoderm-specific activity of the
enhancer (Xu et al., 1998). In the AR2 enhancer, the Smad4
site at2774 is required for enhancer activity in the cardiac
crescent and later in heart development. These findings
reveal an evolutionarily conserved role for Smad factors in
the activation of cardiac NK-type homeobox genes, and
support the notion that Nkx2–5, like tinman, is a direct
target of Smad proteins.
Interestingly, when we compared the mouse AR1 and
AR2 enhancers with the Dpp-responsive tin-D3 enhancer of
Drosophila tinman, we found striking similarities among
these enhancers. The essential Smad site at 2774 adjacent
to the two essential GATA sites and the adjacent 3-
flanking sequences in the AR2 enhancer show high homol-
ogy to the minimal Dpp response element in the tin-D
enhancer (Xu et al., 1998) (Fig. 6). In addition, the core of the
mouse AR1 enhancer (Lien et al., 1999) contains a region
with high homology to the region surrounding the essential
Smad site at 2774 in the AR2 enhancer. This putative
Smad site is also close to the essential GATA site in the
AR1 enhancer that we previously identified (Lien et al.,
1999). However, when we mutated this putative Smad site
in the AR1 enhancer, enhancer activity was not abolished
(E. Lien and E.N.O., unpublished), suggesting there might
be other redundant Smad sites present in the AR1 enhancer.
Liberatore et al. (2002) have also examined the involve-
ment of the Smad sites at the 5 end of the AR2 enhancer.
Consistent with our results, mutations of these binding
sites eliminate activity of the enhancer in the cardiac
crescent. However, these sites are not required for cardiac
expression later in development and the mutant enhancer
actually shows enhanced activity in the right ventricle,
suggesting a negative role for Smad binding to these sites.
Thus, it appears that the AR2 enhancer is a target for
positive and negative regulation by Smad proteins at differ-
ent stages of cardiac development. These divergent modes
of regulation are likely to reflect differential associations of
Smads with positive and negative cofactors that bind
nearby sites in the enhancer.
Smads typically activate transcription in combination
with other cofactors. Since BMPs are expressed in other
regions of the embryo in addition to the cardiogenic region,
the mechanism for BMP-dependent activation of Nkx2–5
must be coupled to other cell-autonomous regulators ex-
pressed prior to Nkx2–5. Understanding how BMP signaling
is interpreted in mesodermal cells by cardiogenic cofactors
is likely to provide insights into the molecular basis for
cardiac specification. In this regard, we have recently found
that Smad4 interacts directly with GATA-4, providing a
possible molecular basis for transcriptional synergy be-
tween these factors and for directly linking cardiac gene
regulation with the BMP signaling pathway (E. Lien and
E.N.O., unpublished).
Evolutionary Considerations
While the transcriptional regulation of Nkx2–5 and tin-
man appear to be similar with respect to the dependence of
the AR2 and tin-D enhancers on BMP signaling through
Smad proteins, there are also fundamental differences in the
regulation of these enhancers. In particular, the tinman
tin-D enhancer is controlled through the combined actions
of Medea and Tinman, whereas Nkx2–5 does not seem to
autoregulate its own expression through the Nkx2–5 bind-
ing site in the AR2 enhancer. On the contrary, it has been
suggested that Nkx2–5 negatively regulates its own expres-
sion (Tanaka et al., 1999), although we observed no evi-
dence for enhanced expression of the enhancer with the
Nkx2–5 binding site mutation, as might be predicted by
such a model.
The differences in regulation of tinman and Nkx2–5
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transcription reflect the differences in mesoderm specifica-
tion and patterning of the vertebrate and arthropod body
plans. tinman is expressed throughout the nascent meso-
derm of Drosophila prior to its subdivision into different
sublineages. Expression of tinman in the early mesoderm is
mediated by binding of Twist to a separate enhancer (Yin et
al., 1997). Specification of the dorsal mesoderm occurs in
response to Dpp signaling from the dorsal ectoderm. In
contrast, Nkx2–5 expression is initiated concomitant with
cardiogenic specification in response to BMP signaling from
the anterior endoderm. Thus, the mechanism for BMP-
dependent activation must be coupled to other cell-
autonomous regulators expressed prior to Nkx2–5 itself.
Understanding how BMP signaling is interpreted in meso-
dermal cells by cardiogenic cofactors is likely to provide
insights into the molecular basis for cardiac specification.
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